CA3022294A1 - Methode et systeme de caracterisation d'affections cutanees - Google Patents
Methode et systeme de caracterisation d'affections cutanees Download PDFInfo
- Publication number
- CA3022294A1 CA3022294A1 CA3022294A CA3022294A CA3022294A1 CA 3022294 A1 CA3022294 A1 CA 3022294A1 CA 3022294 A CA3022294 A CA 3022294A CA 3022294 A CA3022294 A CA 3022294A CA 3022294 A1 CA3022294 A1 CA 3022294A1
- Authority
- CA
- Canada
- Prior art keywords
- kegg
- derived feature
- feature
- skin
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Molecular Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Genetics & Genomics (AREA)
- Data Mining & Analysis (AREA)
- Evolutionary Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662327089P | 2016-04-25 | 2016-04-25 | |
| US201662327126P | 2016-04-25 | 2016-04-25 | |
| US201662327048P | 2016-04-25 | 2016-04-25 | |
| US62/327,126 | 2016-04-25 | ||
| US62/327,048 | 2016-04-25 | ||
| US62/327,089 | 2016-04-25 | ||
| PCT/US2017/029470 WO2017189614A1 (fr) | 2016-04-25 | 2017-04-25 | Méthode et système de caractérisation d'affections cutanées |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3022294A1 true CA3022294A1 (fr) | 2017-11-02 |
Family
ID=60160002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3022294A Pending CA3022294A1 (fr) | 2016-04-25 | 2017-04-25 | Methode et systeme de caracterisation d'affections cutanees |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3448399A4 (fr) |
| CN (1) | CN109152803B (fr) |
| AU (1) | AU2017257785A1 (fr) |
| CA (1) | CA3022294A1 (fr) |
| WO (1) | WO2017189614A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11072832B2 (en) | 2013-06-18 | 2021-07-27 | Prodermiq, Inc. | Customized skin care products and personal care products based on the analysis of skin flora |
| KR102480965B1 (ko) | 2016-09-13 | 2022-12-26 | 알레간 인코포레이티드 | 안정화된 비단백질 클로스트리듐 독소 조성물 |
| CA3055930A1 (fr) | 2017-03-10 | 2018-09-13 | Prodermiq, Inc. | Produits de soin de la peau et produits de soin personnels personnalises selon l'analyse de la flore cutanee |
| JP2021519096A (ja) * | 2018-03-26 | 2021-08-10 | プロダームアイキュー,インク. | ざ瘡を処置するための組成物および方法 |
| BR112020017257A2 (pt) * | 2018-03-29 | 2020-12-22 | Kimberly-Clark Worldwide, Inc. | Sensor, artigo absorvente, e, método para indicar um potencial problema de pele ou gastrointestinal. |
| BR112023026959A2 (pt) * | 2021-07-05 | 2024-03-12 | Unilever Ip Holdings B V | Métodos para avaliar uma composição cosmética, preparar um meio gravável para demonstrar o resultado da avaliação de uma composição cosmética e demonstrar o resultado da avaliação de uma composição cosmética |
| US20250290158A1 (en) * | 2021-07-05 | 2025-09-18 | Conopco Inc., D/B/A Unilever | Method for assessing skin |
| CN117337901B (zh) * | 2023-09-28 | 2026-04-24 | 广西农垦西江乳业有限公司 | 一种低致敏乳源蛋白基料的制备方法 |
| CN118272552B (zh) * | 2024-03-29 | 2025-02-14 | 美益添生物医药(武汉)有限公司 | 源于肠道菌群的白癜风检测标志物及其应用 |
| CN118230890A (zh) * | 2024-05-24 | 2024-06-21 | 西安润玉医疗科技有限公司 | 一种基于术后皮肤检测数据的产品匹配方法及系统 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012098238A1 (fr) * | 2011-01-21 | 2012-07-26 | Novimmune S.A. | Associations thérapeutiques et méthodes d'utilisation d'agents modulateurs anti-cd3 et d'antagonistes anti-il-6 |
| WO2012158818A2 (fr) * | 2011-05-16 | 2012-11-22 | Fabion Pharmaceuticals, Inc. | Protéines de fusion contenant un fab multi-spécifique et procédé d'utilisation |
| EP2825676B1 (fr) * | 2012-03-17 | 2017-12-20 | The Regents of The University of California | Diagnostic rapide et traitements personnalisés de l'acné |
| US10131710B2 (en) * | 2013-01-14 | 2018-11-20 | Xencor, Inc. | Optimized antibody variable regions |
| EP2961770A1 (fr) * | 2013-02-26 | 2016-01-06 | Roche Glycart AG | Molécules bispécifiques de liaison à l'antigène activant les lymphocytes t |
| CN105283201B (zh) * | 2013-03-14 | 2019-08-02 | 斯克利普斯研究所 | 靶向剂抗体偶联物及其用途 |
| US11072832B2 (en) * | 2013-06-18 | 2021-07-27 | Prodermiq, Inc. | Customized skin care products and personal care products based on the analysis of skin flora |
| AU2014346562B2 (en) * | 2013-11-07 | 2018-11-29 | The Board Of Trustees Of The Leland Stanford Junior University | Cell-free nucleic acids for the analysis of the human microbiome and components thereof |
| AU2015209718B2 (en) * | 2014-01-25 | 2021-03-25 | Macrogen Inc. | Method and system for microbiome analysis |
| WO2016065075A1 (fr) * | 2014-10-21 | 2016-04-28 | uBiome, Inc. | Procédé et système de diagnostic et de thérapie fondés sur le microbiome |
| AU2016250100A1 (en) * | 2015-04-13 | 2017-11-09 | Psomagen, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions |
| CN108699586B (zh) * | 2016-03-07 | 2022-09-20 | 普梭梅根公司 | 用于表征与口相关病症的方法和系统 |
-
2017
- 2017-04-25 CA CA3022294A patent/CA3022294A1/fr active Pending
- 2017-04-25 WO PCT/US2017/029470 patent/WO2017189614A1/fr not_active Ceased
- 2017-04-25 EP EP17790288.9A patent/EP3448399A4/fr active Pending
- 2017-04-25 CN CN201780030413.6A patent/CN109152803B/zh active Active
- 2017-04-25 AU AU2017257785A patent/AU2017257785A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3448399A1 (fr) | 2019-03-06 |
| CN109152803B (zh) | 2022-09-23 |
| AU2017257785A1 (en) | 2018-11-08 |
| EP3448399A4 (fr) | 2020-05-13 |
| CN109152803A (zh) | 2019-01-04 |
| WO2017189614A1 (fr) | 2017-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10169541B2 (en) | Method and systems for characterizing skin related conditions | |
| US10381117B2 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions | |
| US10383519B2 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features | |
| US10366793B2 (en) | Method and system for characterizing microorganism-related conditions | |
| US10358682B2 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features | |
| CA3022294A1 (fr) | Methode et systeme de caracterisation d'affections cutanees | |
| US10265009B2 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features | |
| US10246753B2 (en) | Method and system for characterizing mouth-associated conditions | |
| US10381112B2 (en) | Method and system for characterizing allergy-related conditions associated with microorganisms | |
| US20170235902A1 (en) | Method and system for characterization of clostridium difficile associated conditions | |
| AU2016321349A1 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with gastrointestinal health | |
| AU2022200243A1 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions | |
| AU2016366656A1 (en) | Method and system for characterization of Clostridium difficile-associated conditions | |
| WO2018112459A1 (fr) | Procédé et système destinés à la caractérisation d'états pathologiques apparentés à un microorganisme | |
| EP3775257A1 (fr) | Procédé et système pour caractériser des affections liées à une allergie et associées à des micro-organismes | |
| CA3007503C (fr) | Procede et systeme de caracterisation d'affections associees a clostridium difficile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20211129 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20240821 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250103 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250324 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250324 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250324 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250422 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250422 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D149 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S INTERVIEW Effective date: 20250526 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20250603 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250605 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250721 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250723 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT Effective date: 20251118 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251118 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-4-4-D10-D00-D164 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: RESPONSE TO NOTICE OF ALLOWANCE Effective date: 20260128 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 9TH ANNIV.) - STANDARD Year of fee payment: 9 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260324 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260324 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-4-D10-D22-D143 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRE-GRANT Effective date: 20260422 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260422 |